Any systemic treatment vs placebo
Certolizumab · people with chronic plaque psoriasis
Any systemic treatment probably leads to higher certolizumab compared with placebo (moderate certainty).
2 findings from 1 review
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 12.11 [8.78, 16.71]4 studies · 1026 participantsModerate
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 0.74 [0.31, 1.75]4 studies · 1026 participantsLow